Skip to content

An study to determine the changes in genes leading to abnormalities of nervous system in India.

Genetic diagnosis of neurodevelopmental disorders in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/10/016063
Enrollment
500
Registered
2018-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder Health Condition 2: F809- Developmental disorder of speech and language, unspecified Health Condition 3: F70- Mild intellectual disabilities Health Condition 4: F71- Moderate intellectual disabilities Health Condition 5: F808- Other developmental disorders of speech and language Health Condition 6: F88- Other disorders of psychological development Health Condition 7: F78- Other intellectual disabilities Health Condition 8: F848- Other pervasive develop

Interventions

None listed

Sponsors

National Institutes of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria includes subjects with neurodevelopment disorders. The study will not discriminate on the basis of race, sex, or religion. We anticipate males and females will be enrolled in roughly equal numbers.

Exclusion criteria

Exclusion criteria: Subjects with a recognizable genetic syndrome or with an evidence of a non-genetic factor contributing to NDD would be excluded from the study.

Design outcomes

Primary

MeasureTime frame
This proposal would result in identifying genetic etiology for a spectrum of neurodevelopmental disorders by the application of CMA and WES technologies. Genetic diagnoses can lead to therapeutic interventions that improve the quality of life and provide options for carrier and prenatal testing with power to reduce the disease burden.Timepoint: 5 years

Secondary

MeasureTime frame
The international educational exchange will develop experienced personnel for this project, and shape national standards for genetic testing, management of genomic information in India.Finally, our resource investment in a populations-specific database and sample biorepository are the foundation for future studies to uncover novel genetic mechanisms of NDDs â?? both within and outside the exome and explore their impact on normal brain development and pathophysiology.Timepoint: 5 years

Countries

India

Contacts

Public ContactDr Anju Shukla

Kasturba Medical College and Hospital, Manipal

anju.shukla@manipal.edu9980447131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026